User profiles for R. De Angelis

Rossella De Angelis

- Verified email at staff.univpm.it - Cited by 4940

Roberta De Angelis

- Verified email at cardiff.ac.uk - Cited by 1100

The clinical features of rheumatoid arthritis

W Grassi, R De Angelis, G Lamanna… - European journal of …, 1998 - Elsevier
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by progressive
damage of synovial-lined joints and variable extra-articular manifestations. Tendon and bursal …

[HTML][HTML] Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis

…, AL Herrick, F Ingegnoli, N Damjanov, R De Angelis… - Autoimmunity …, 2020 - Elsevier
… e 1 , Francesca Ingegnoli f g 1 , Nemanja Damjanov h , Rossella De Angelis i , Christopher
P. … Rossella De Angelis: Analysis and interpretation of data, drafting of the article, critical …

Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study

R De Angelis, M Sant, MP Coleman, S Francisci… - The lancet …, 2014 - thelancet.com
Background Cancer survival is a key measure of the effectiveness of health-care systems.
EUROCARE—the largest cooperative study of population-based cancer survival in Europe—…

[HTML][HTML] Cancer survival in five continents: a worldwide population-based study (CONCORD)

…, JM Lutz, R De Angelis, R Capocaccia… - The lancet …, 2008 - thelancet.com
Background Cancer survival varies widely between countries. The CONCORD study provides
survival estimates for 1·9 million adults (aged 15–99 years) diagnosed with a first, primary, …

Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project

…, R De Angelis, R Capocaccia… - Blood, The Journal …, 2010 - ashpublications.org
Changing definitions and classifications of hematologic malignancies (HMs) complicate
incidence comparisons. HAEMACARE classified HMs into groupings consistent with the latest …

Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study

F Berrino, R De Angelis, M Sant, S Rosso… - The lancet …, 2007 - thelancet.com
… and case-mix-adjusted relative survival for all cancers combined and TNEH (r 2 =0·56 for
females, r 2 =0·43 for males). However, Denmark and UK had … De Angelis R Capocaccia R

[HTML][HTML] Measuring cancer prevalence in Europe: the EUROPREVAL project

R Capocaccia, M Colonna, I Corazziari, R De Angelis… - Annals of …, 2002 - Elsevier
… As shown by Capocaccia and De Angelis [18], R is not influenced by absolute incidence
levels, but only by the age slope of incidence. R is larger for cancers the incidence of which …

[HTML][HTML] Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study

…, A Trama, D Serraino, A Zucchetto, R De Angelis… - European journal of …, 2015 - Elsevier
Background Head and neck (H&N) cancers are a heterogeneous group of malignancies,
affecting various sites, with different prognoses. The aims of this study are to analyse survival …

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study

…, L Botta, S Mallone, R De Angelis… - The Lancet …, 2017 - thelancet.com
Background Rare cancers pose challenges for diagnosis, treatments, and clinical decision
making. Information about rare cancers is scant. The RARECARE project defined rare …

Supply chain management and the circular economy: towards the circular supply chain

R De Angelis, M Howard… - Production Planning & …, 2018 - Taylor & Francis
… Roberta De Angelis is a recent PhD graduate in management studies from the University of
Exeter Business School, UK. Her doctoral research has focussed on business models based …